NCT06993038View on ClinicalTrials.gov

Adenosine vs Diltiazem for Treatment of SVT in the ED

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Supraventricular Tachycardia (SVT)
Interventions
DRUG

adenosine

IV adenosine at standard doses for SVT (6 mg, 12 mg)

DRUG

diltiazem

IV diltiazem at standard doses for SVT (0.25 mg/kg)

Trial Locations (1)

52242

RECRUITING

University of Iowa Health Care, Iowa City

All Listed Sponsors
lead

Anne E. Zepeski

OTHER